Gallbladder Cancer and Gallstones: The Link, Risks & Prevention
- Is there a link between gallstones and gallbladder cancer?
- Risk factors for gallbladder cancer (large stones, porcelain gallbladder)
- Symptoms of gallbladder cancer – often silent until advanced
- Diagnosis – ultrasound, CT, MRI, CA 19‑9, biopsy
- Staging and prognosis
- Treatment – surgery, chemotherapy, radiation
- Prevention – when to consider prophylactic cholecystectomy
- Interactive FAQ – 9 common questions
Is there a link between gallstones and gallbladder cancer?
Yes, chronic gallstone disease is a well‑established risk factor for gallbladder cancer (GBC). However, the absolute risk remains very low. Approximately 70‑90% of patients with gallbladder cancer have gallstones at diagnosis. Chronic inflammation from repeated episodes of cholecystitis and mechanical irritation from stones are thought to cause dysplasia and malignant transformation over decades. The risk increases with stone size, duration of disease, and presence of calcification (porcelain gallbladder). Despite the association, fewer than 1% of patients with gallstones develop gallbladder cancer.
Risk factors for gallbladder cancer (large stones, porcelain gallbladder)
Specific risk factors that increase the likelihood of gallbladder cancer in patients with gallstones include:
- Large gallstones (>3cm): Risk increases 5‑10 fold compared to stones <1cm. Large stones cause more chronic inflammation.
- Porcelain gallbladder (calcified wall): Associated with a 5‑15% risk of cancer. Prophylactic cholecystectomy is recommended.
- Long‑standing gallstones (>20‑30 years).
- Gallbladder polyps >10mm: May be malignant or premalignant.
- Anomalous pancreaticobiliary duct junction (APBDJ): Congenital anomaly with high cancer risk.
- Chronic typhoid carrier state (Salmonella typhi).
- Primary sclerosing cholangitis (PSC).
Other risk factors not related to gallstones: female sex (3:1), age >65, obesity, diabetes, and certain ethnic groups (Native Americans, Chileans, North Indians).
Symptoms of gallbladder cancer – often silent until advanced
Early gallbladder cancer is usually asymptomatic. Symptoms, when present, mimic advanced gallstone disease:
- Right upper quadrant pain (dull, constant).
- Unexplained weight loss and anorexia.
- Jaundice (if tumour obstructs the bile duct).
- Palpable mass in the right upper quadrant.
- Nausea and vomiting.
- Fever (if secondary infection).
Diagnosis – ultrasound, CT, MRI, CA 19‑9, biopsy
Diagnosis is often incidental during cholecystectomy or imaging for other reasons:
- Abdominal ultrasound: First‑line. May show a thickened gallbladder wall, a mass protruding into the lumen, or replacement of the gallbladder by tumour.
- Contrast‑enhanced CT scan: Essential for staging. Shows local invasion, liver metastases, lymph node involvement, and distant spread.
- MRI/MRCP: Superior for assessing bile duct invasion and vascular involvement.
- Tumour marker CA 19‑9: Elevated in 60‑80% of cases, but not specific (can be elevated in cholangitis).
- Biopsy: Percutaneous or endoscopic (EUS‑guided) biopsy of suspicious lesions. Biopsy of the gallbladder wall is rarely done pre‑operatively if resectable.
Staging and prognosis
Gallbladder cancer is staged according to the TNM system (AJCC 8th edition):
- Stage I: Tumour confined to the gallbladder wall (T1‑2). 5‑year survival 50‑80% with complete resection.
- Stage II: Tumour invades beyond the serosa into the liver or adjacent structures (T3). 5‑year survival 20‑40%.
- Stage III: Involvement of regional lymph nodes. 5‑year survival 10‑20%.
- Stage IV: Distant metastases or extensive local invasion. 5‑year survival <5%.
Most patients present at stage III or IV, explaining the poor overall prognosis.
Treatment – surgery, chemotherapy, radiation
Treatment depends on stage and resectability:
- Surgical resection (only curative option):
- Simple cholecystectomy: For T1a tumours (confined to mucosa) discovered incidentally after cholecystectomy.
- Radical cholecystectomy (extended): For T1b and higher. Includes resection of the gallbladder bed (liver segment IVb/V), lymphadenectomy, and possible bile duct excision.
- Extended resections: For locally advanced disease (pancreaticoduodenectomy, major hepatectomy) in select centres.
- Chemotherapy: Adjuvant (after surgery) for high‑risk patients (T2+, node‑positive). Regimens include gemcitabine + cisplatin or capecitabine. Palliative chemotherapy for metastatic disease.
- Radiation therapy: Limited role; may be used for palliation or in combination with chemotherapy.
- Palliative care: For advanced unresectable disease – biliary stenting for jaundice, pain management, nutritional support.
Prevention – when to consider prophylactic cholecystectomy
Given the low absolute risk, routine cholecystectomy for asymptomatic gallstones is not recommended. However, prophylactic cholecystectomy should be considered in:
- Porcelain gallbladder (5‑15% cancer risk).
- Gallbladder polyps >10mm (increasing risk of malignancy).
- Large gallstones (>3cm) in high‑risk populations (Native American, Chilean, North Indian).
- Anomalous pancreaticobiliary duct junction (APBDJ).
- Patients undergoing bariatric surgery or organ transplantation (incidental cholecystectomy).
Interactive FAQ – Gallbladder cancer and gallstones
Less than 1%. The absolute risk is very low, but the relative risk is increased compared to those without stones.
Chronic gallstone disease, especially large stones (>3cm) and porcelain gallbladder.
Yes, if detected at an early stage (T1a or T1b) and completely resected. However, most cases are diagnosed late.
Overall less than 20%. For stage I, 50‑80%; stage II, 20‑40%; stage III, 10‑20%; stage IV, <5%.
It is controversial. Many guidelines recommend observation, but some surgeons advise prophylactic cholecystectomy for very large stones due to a small increase in cancer risk. Discuss with your doctor.
A calcified gallbladder wall due to chronic inflammation. It carries a 5‑15% risk of gallbladder cancer, so prophylactic cholecystectomy is recommended.
Yes – ultrasound can show a thickened wall, a mass, or calcification. However, CT and MRI are needed for staging.
CA 19‑9 is often elevated but not specific. It can be used for monitoring treatment response and detecting recurrence.
Yes – cholecystectomy removes the organ at risk. That is why prophylactic cholecystectomy is considered for high‑risk conditions like porcelain gallbladder.
Disclaimer: This information is for educational purposes. If you have gallstones and are concerned about cancer risk, consult a gastroenterologist or surgeon at Vivekananda Hospital for personalised advice.